Wilhelmina M H Eijkenboom
Overview
Explore the profile of Wilhelmina M H Eijkenboom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Jong P, Mooy C, Stoter G, Eijkenboom W, Luyten G
Ophthalmology
. 2006 Apr;
113(6):1040-4.
PMID: 16631255
Purpose: To describe the documented growth, clinical course, and histopathology of retinoblastomas in an untreated and otherwise normal right eye of a 27-year-old white male with a g.153211T>A (p.Tyr606X) mutation...
2.
Homs M, Steyerberg E, Eijkenboom W, Siersema P
Brachytherapy
. 2006 Mar;
5(1):41-8.
PMID: 16563996
Background: Single-dose brachytherapy is a commonly used palliative treatment modality for esophageal carcinoma, however, a considerable number of patients need additional treatment for persistent or recurrent dysphagia. Our aim was...
3.
Kilic E, Stijnen T, de Jong P, Mooy C, Eijkenboom W, Ringens P, et al.
Arch Ophthalmol
. 2005 Oct;
123(10):1363-7.
PMID: 16219727
Background: Radiotherapy of an eye before enucleation, so called preenucleation radiotherapy (PER), of patients with uveal melanoma was initiated to reduce enucleation-induced systemic metastasis. Earlier studies with a short follow-up...
4.
Homs M, Steyerberg E, Eijkenboom W, Tilanus H, Stalpers L, Bartelsman J, et al.
Lancet
. 2004 Oct;
364(9444):1497-504.
PMID: 15500894
Background: Both single-dose brachytherapy and self-expanding metal stent placement are commonly used for palliation of oesophageal obstruction due to inoperable cancer, but their relative merits are unknown. We undertook a...
5.
Homs M, Eijkenboom W, Coen V, Haringsma J, van Blankenstein M, Kuipers E, et al.
Radiother Oncol
. 2003 May;
66(3):327-32.
PMID: 12742273
Background And Purpose: High dose rate (HDR) brachytherapy is a commonly used palliative treatment for esophageal carcinoma. We evaluated the outcome of HDR brachytherapy in patients with malignant dysphagia. Material...